ArticleBiomimetics (Basel, Switzerland)2025
A Multi-Strategy Improved Red-Billed Blue Magpie Optimizer for Global Optimization.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multi-Strategy Improved Red-Billed Blue Magpie Optimization Algorithm and Its Engineering Applications.Biomimetics (Basel, Switzerland) · 2026Article
- Enhanced Red-billed Blue Magpie Optimizer for engineering optimization problems.Scientific reports · 2026Article
- An Enhanced Red-Billed Blue Magpie Optimizer Based on Superior Data Driven for Numerical Optimization Problems.Biomimetics (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To enhance the convergence efficiency and solution precision of the Red-billed Blue Magpie Optimizer (RBMO), this study proposes a Multi-Strategy Enhanced Red-billed Blue Magpie Optimizer (MRBMO). The principal methodological innovations encompass three aspects: (1) Development of a novel dynamic boundary constraint handling mechanism that strengthens algorithmic exploration capabilities through adaptive regression strategy adjustment for boundary-transgressing particles; (2) Incorporation of an elite guidance strategy during the predation phase, establishing a guided search framework that integrates historical individual optimal information while employing a Lévy Flight strategy to modulate search step sizes, thereby achieving effective balance between global exploration and local exploitation capabilities; (3) Comprehensive experimental evaluations conducted on the CEC2017 and CEC2022 benchmark test suites demonstrate that MRBMO significantly outperforms classical enhanced algorithms and exhibits competitive performance against state-of-the-art optimizers across 41 standardized test functions. The practical efficacy of the algorithm is further validated through successful applications to four classical engineering design problems, confirming its robust problem-solving capabilities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.